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Abstract
Background: A336C/A336T/T337C variations in HBV core gene were demonstrated to relate to the decreases in
serum HBV DNA levels and HBV replication in chronic hepatitis B patients. Usually the drastic decrease in serum
HBV DNA levels correlates with spontaneous HBeAg loss during the course of chronic HBV infection. The aim of
the present study was to investigate whether there was correlation between A336C/A336T/T337C variations and
spontaneous HBeAg loss
Methodology/Principal Findings: A modified PCR-RFLP assay and ELISA were adopted to determine A336C/
A336T/T337C variations and serum HBeAg levels in chronic hepatitis B patients without any antiviral therapy,
respectively, whereas G1896A variation and HBV genotype were detected using Taqman-PCR assay. RFLP pattern C,
E, G, C/G mixture and a new pattern C’ were found in this study. A336C/A336T/T337C variations occurred in 40/166
(24.1%) chronic hepatitis B patients. Chi-square test showed that C336/T336/C337 variants was more frequent in
chronic hepatitis B patients with A1896 variants than those with the wild type G1896 (c2 = 4.7, P = 0.03), and
moreover, patients with C336/T336/C337 variants had a significantly lower HBeAg-positive percentage than those
with the wild type A336/T337. Binary logistic regression identified genotype B (OR = 4.1, 95%CI = 1.8-9.2, P =
0.001), the presence of C336/T336/C337 variants (OR = 3.2, 95%CI = 1.2-8.5, P = 0.02) and A1896 variants (OR = 7.8,
95%CI = 3.3-18.5, P < 0.001) as independent factors associated with spontaneous HBeAg loss.
Conclusion/Significance: A336C/A336T/T337C were naturally occurring polymorphisms in HBV core gene, and
moreover, the presence of C336/T336/C337 variants was first demonstrated to be an independent factor
associating with spontaneous HBeAg loss in chronic hepatitis B patients.
Background
Infection with the hepatitis B virus (HBV) remains a very
important human disease, with an estimated 400 million
people infected chronically worldwide. It is reported that
about 1.5 million people die annually as a result of infec-
tion, most of them in Asia and Africa. In China, chronic
HBV infection is also a major public health problem and
associated with a wide range of clinical states, from an
asymptomatic carrier state with a normal liver function
to severe liver disease, which includes liver cirrhosis and
hepatocellular carcinoma [1,2].
Spontaneous hepatitis B e antigen (HBeAg) loss during
the course of chronic HBV infection is usually accompa-
nied by the disappearance of the biochemical markers of
hepatitis and a drastic decrease in viral replication. Factors
associated with a higher rate of spontaneous HBeAg loss
include certain HBV genotypes and certain HBV genetic
diversities. Currently, HBV is classified into eight geno-
types (A-H) based on an intergroup divergence of 8% or
more in the complete nucleotide sequence of viral gen-
omes. Genotypes B and C are prevalent in China. Previous
cross-sectional and retrospective studies showed that gen-
otype B patients had a significantly lower prevalence of
HBeAg at presentation and a significantly higher rate of
spontaneous HBeAg loss than genotype C [3-6]. In addi-
tion to genotype B, G1896A variation, not A1762T/
G1764A dual variations, is proposed to be another major
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ural history of chronic HBV infection [7,8]. G1896A varia-
tion was mainly present in patients who were HBeAg-
negative natives of Asian or Mediterranean basin, whereas
A1762T/G1764A dual variations were detected in a similar
proportion of HBeAg-negative and HBeAg-positive
patients [6,9-12].
A336C/A336T/T337C variations in HBV core gene,
destroying the cleavage sites of Tsp509I, were demon-
strated to correlate with the decreases in serum HBV
DNA levels and HBV replication in chronic hepatitis B
patients, and moreover, A336C/A336T variations caused
the substitution of Glu-83 with Asp in HBcAg [13].
HBeAg is transcribed from the precore/core gene like
HBcAg, therefore, A336C/A336T variations also cause the
change of amino acid composition of HBeAg. Recent stu-
dies showed HBeAg up-regulation resulted in the decrease
in TLR levels, which protected HBV from the immune
response and led to higher HBV DNA viral load in HBeAg
positive patients [14,15]. In addition, one multicenter
study found that HBeAg titre correlated positively with
serum HBV DNA and HBV replication [16]. Therefore, it
was reasonable to suspect that A336C/A336T/T337C var-
iations caused the decrease in serum HBV DNA levels by
down-regulating HBeAg expression or promoting HBeAg
loss. In order to investigate whether there was correlation
between A336C/A336T/T337C variations and sponta-
neous HBeAg loss, the cumulative rates of spontaneous
HBeAg loss between patients with C336/T336/C337 var-
iants and the wild type A336/T337 were compared by ana-
lyzing a cohort of 166 Chinese chronic hepatitis B patients
without any antiviral therapy.
Methods
Patients, samples and the extraction of HBV DNA
This is a cross-sectional study using stored serum sam-
ples from 166 chronic hepatitis B patients with genotype
B and genotype C in Union Hospital of Huazhong Uni-
versity of Science and Technology in 2009. Chronic HBV
infection was defined as persistent positivity for hepatitis
B surface antigen (HBsAg) for at least six months at pre-
sentation. Patients with malignancy, liver cirrhosis, anti-
HCV positivity, anti-HIV positivity and autoimmune dis-
ease were excluded. Before collecting blood samples, all
patients had never been treated with any antiviral ther-
apy. Informed consent was obtained from all of the
patients. The study was approved by the Ethics Commit-
tee of Union Hospital, Tongji Medical College, Huazhong
University of Science and Technology. Serum samples
were stored at -80°C before they were tested. HBV DNA
was extracted from 100 μl of serum with extraction solu-
tion in a PCR-fluorescence quantification kit for HBV
(Kelong, Shanghai, China) by the protocol described by
the manufacturer.
Serology
HBsAg, HBeAg, anti-HBs antibodies, anti-HBc antibo-
dies, anti-HBe antibodies, anti-HCV and anti-HIV anti-
bodies were determined with commercial assay kits
(InTec, Xiamen, China).
Real-time quantification of serum HBV-DNA
Quantification of serum HBV-DNA was carried out by
real-time PCR assay using the method described before
[13]. HBV-DNA levels were expressed as log copies/ml.
HBV core gene specific PCR-RFLP (polymerase chain
reaction-restriction fragment length polymorphism) assay
and HBV core gene sequencing
The presence of HBV core gene A336C/A336T/T337C
variations in patient’s sera were determined by a modi-
fied PCR-RFLP assay and cleaved PCR products were
electrophoresed on 2.5% agarose gel [13,17], and five
PCR amplicons per RFLP pattern were sequenced
directly to confirm the accuracy of PCR-RFLP assay.
The restriction enzyme Tsp509I and primers for amplifi-
cation and sequencing were in agreement with those
used in reference [13].
Detection of G1896A variation in HBV core gene
G1896A variation in HBV core gene was detected with
PCR-fluorescence detection kit based on Taqman MGB
(minor groove binder) probes (Biocore, Hangzhou, China).
The amplification and detection were carried out using
the LightCycler
® Systems for real-time PCR (Roche Diag-
nostic, Switzerland). For each sample, real-time PCR reac-
tion A and B were performed in two different capillary
tubes according to the instructions of the manufacturer.
In brief, the real-time PCR reaction was carried out in a
final volume of 20.4 μl, consisting of 18.4 μlo fm a s t e r
reaction mixture A or B and 2 μl of DNA template. Ther-
mal cycling conditions were as follows: One cycle of 37°C
for two minutes and 94°C for two minutes, followed by 35
cycles of 93°C for five seconds and 62°C for 30 seconds at
a programmed temperature transition rate of 20°C/s, then
cooled at 40°C for less than one second. Monitoring of
fluorescence intensity occurred at regular intervals during
the annealing-extension phase. The recombinant plasmids
including wild type G1896(or A1896 mutant) were used as
negative control(or positive control). Ct value obtained
from real-time PCR was adopted to identify wild type
G1896 and A1896 mutant and the identification standards
were list in Table 1.
HBV genotyping
HBV was genotyped with PCR-fluorescence diagnosis kit
b a s e do nT a q m a np r o b e s( K e long, Shanghai, China).
The amplification and detection were carried out with
the MXP3000
® real-time thermocycler (Stratagene, La
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in eppendorf tube according to the instruction provided
by the manufacturer. In brief, the real-time PCR reac-
tion was carried out in a final volume of 30 μl, consist-
ing of 26 μl of master reaction mixture and 4 μlo f
DNA template. Real time PCR program consisted of
heating at 50°C for 2 minutes and 94°C for 5 minutes,
followed by 40 cycles of a two stage temperature profile
of 93°C for 15 seconds and 60°C for 45 seconds at a
programmed temperature transition rate of 3°C/s. Fluor-
escence emitted from reporter dyes FAM and Hex™
was monitored at regular intervals during the annealing-
extension phase respectively. Ct value obtained from
real-time PCR was adopted to identify HBV genotypes
and the identification standards were list in Table 1.
Statistical analysis
Statistical analysis was carried out with the SPSS 15.0
software package. Chi-square test was used for compari-
son of categorical data. Binary logistic regression analysis
was adopted to estimate the independent factors associat-
ing with spontaneous HBeAg loss. During statistical ana-
lysis, serum ALT(alanine aminotransferase) levels, serum
HBV DNA levels and age were transformed into categori-
cal variables, respectively: (1) serum ALT levels were
categorized into normal group(≤50 U/L) and abnormal
group (>50 U/L); (2) serum HBV DNA levels were cate-
gorized into mild elevated group (<6.0) and severely ele-
vated group(≧6.0); (iii)age were grouped into <35 years
and ≧35 years. The results were presented as odds ratios
(OR), 95% confidence intervals (CI), wald values and P
values. P ≤ 0.05 was considered statistically significant.
Results
RFLP patterns and A336C/A336T/T337C variations in
chronic hepatitis B patients
A336C/A336T/T337C variations in HBV core gene were
determined with a modified PCR-RFLP assay on total
166 serum samples collected from chronic hepatitis B
patients. Five RFLP patterns cleaved by restriction
enzyme Tsp509I, namely RFLP C, C’,E ,Ga n dC / G
mixture were found. RFLP C’ was a new pattern found
in this study(see Figure 1). RFLP C, C’,E ,Ga n dC / G
mixture occurred in 101(60.8%),1(0.006%) 24(14.5%),27
(16.3%),13(7.8%) samples, respectively. Sequencing of
HBV core gene demonstrated complete match between
RFLP patterns and SNPs (single nucleotide polymorph-
isms) A336C/A336T/T337C (data not shown). Sequen-
cing also showed that A336C/A336T/T337C variations
occurred in serum samples presenting with RFLP pat-
terns G and C/G mixture (A336C/A336T/T337C varia-
tions were found in part of HBV DNA from serum
samples with RFLP patterns C/G mixture, therefore,
serum samples showing RFLP C/G mixture were also
considered to be presence of C336/T336/C337 variants).
A336C/A336T/T337C variations occurred in 40/166
(24.1%) chronic hepatitis B patients without any antiviral
therapy (See Table 2).
A336C/A336T/T337C variations correlated with G1896A
variation and the decrease in serum HBV DNA levels
G1896A was the most common variation in precore
gene and occurred in 75/166(45.2%) chronic hepatitis B
patients in this study. C336/T336/C337 variants were
found in 24/75 (32.0%) chronic hepatitis B patients with
A1896 variants and 16/91(17.6%) chronic hepatitis B
patients with the wild type G1896. Chi-square test
showed C336/T336/C337 variants were more frequent
in chronic hepatitis B patients with A1896 variants than
those with the wild type G1896 (c2 = 4.7, P = 0.03),
suggesting that A336C/A336T/T337C variations corre-
lated closely with G1896A variation (See Table 2). In
addition, patients with C336/T336/C337 variants had a
significant lower rate of severely elevated serum HBV
DNA levels than those with the wild type A336/T337
(c2 = 6.6, P = 0.01).
HBV genotype was determined on total of 166 chronic
hepatitis B patient with Taqman-PCR assay. Of the 166
patients, 87 (52.4%) were infected with HBV genotype B
and the remaining 79 (47.6%) were infected with geno-
type C. A336C/A336T/T337C variations occurred in 26/
87 (29.9%) chronic hepatitis B patients with genotype B
and 14/79 (17.7%) patients with genotype C, and Chi-
square test showed that there was no significant differ-
ence in the rate of A336C/A336T/T337C variations
between HBV genotype B and C (c2 = 3.3, P = 0.07, See
Table 2).
The presence of C336/T336/C337 variants was an
independent factor associating with spontaneous HBeAg
loss in chronic Hepatitis B patients
In this study, HBeAg was found in 77/166(46.4%)
chronic hepatitis B patients. Chi-square test showed
chronic hepatitis B patients with C336/T336/C337 var-
iants had a significantly lower HBeAg-positive percen-
tage than those with the wild type A336/T337(22.5% vs
54.0%, c2 = 12.1, P = 0.001), indicating that the
Table 1 The standards for identifying HBV genotypes,
G1896 and A1896
Identification standards
A1896 Ct(A)≤38 and Ct(B)≥40
G1896 Ct(A)≤38 and Ct(B)≤38
Genotype B Ct(FAM)≤36 and Ct(Hex)≥40
Genotype C Ct(FAM)≥40 and Ct(Hex)≤36
Genotype B/C mixture Ct(FAM)≤36 and Ct(Hex)≤36
Uncertain Genotype Ct(FAM)≥40 and Ct(Hex)≥40
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ciated with spontaneous HBeAg loss in chronic hepatitis
B patients (See Table 3). Furthermore, Chi-square test
also showed that the presence of A1896 variant, age ≧35
years, HBV genotype B and serum HBV DNA levels
<6.0 were also related closely to spontaneous HBeAg
loss in chronic hepatitis B patients (See Table 3),
therefore, A336C/A336T/T337C variations, serum HBV
DNA levels, G1896A variation, age and HBV genotype
were entered into a binary logistic regression model to
determine which was the independent factor associating
with spontaneous HBeAg loss. The results of the analy-
sis were displayed in Table 4. Although the presence of
501bp
404bp
331bp
242bp
190bp
147bp
111bp
(a)
M       1        2                                      3
(b)
(c)
(d)
Figure 1 HBV core gene RFLP pattern C’(M. DNA marker;1. RFLP E;2. RFLP C’ 3.C l e a v a g es i t eo fTsp509I were found at position 61(b),116
(c),261 and 286(d) corresponding to nucleotide 110,165,310 and 335 in HBV core gene showing RFLP C’, respectively).
Table 2 Comparison of important characteristics between
166 patients with the wild type A336/T337 and A336C/
A336T/T337C variants
A336/T337
(n = 126)
C336/T336/C337
(n = 40)
c2 p value
HBeAg 12.1 0.001
Positive 68 9
Negative 58 31
G1896 variation 4.7 0.03
G1896 75 16
A1896 51 24
HBV genotype 3.4 0.07
B6 1 2 6
C6 5 1 4
serum HBV DNA levels
<6 69 31 6.6 0.01
≥65 7 9
Age
<35 62 18 0.2 0.64
≥35 64 22
Sex 2.4 0.12
Male 100 27
Female 26 13
Serum ALT levels 0.1 0.74
≤50 U/L 75 25
>50 U/L 51 15
Table 3 Comparison of important characteristics between
166 patients with positive HBeAg and negative HBeAg
HBeAg
positive
(n = 77)
HBeAg
negative
(n = 89)
c2P
value
A336C/A336T/T337C
variations
12.1 0.001
A336/T337 68 58
C336/T336/C337 9 31
G1896 variation 42.3 <0.001
G1896 63 28
A1896 14 61
HBV genotype 14.8 <0.001
B2 8 5 9
C4 9 3 0
serum HBV DNA levels 23.9 <0.001
<6 31 69
≥64 6 2 0
Age 4.6 0.03
<35 44 36
≥35 33 53
Sex 0.001 0.94
Male 59 68
Female 18 21
Serum ALT levels 3.2 0.07
≤50 U/L 52 48
>50 U/L 25 41
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and HBV genotype B(OR = 4.1, 95% CI = 1.8-9.2, P =
0.001) were the most two importantly independent fac-
tors associating with spontaneous HBeAg loss, the pre-
sence of C336/T336/C337 variants was also an
independent factor associating with spontaneous HBeAg
loss(OR = 3.2, 95% CI = 1.2-8.5, P = 0.02) (See Table 4).
Discussion
Recent studies have identified several HBV variants and
mutants playing an important role in disease pathogen-
esis, immune escape, and resistance to antiviral therapy
[18,19]. HBV variants such as A1896 occur under the
selective pressures from the host’s immune system and
from viral factors [20,21], whereas HBV mutants, such as
rtI204 and rtV204, usually occur secondary to exogenous
factors such as lamivudine and associate with a specific
phenotype [12,22]. In this cross-sectional study, 166
serum samples from chronic hepatitis B patients without
any antiviral therapy were enrolled, and A336C/A336T/
T337C variations and G1896A variation occurred in
24.1% (40/166) and 45.2% (75/166) serum samples,
respectively. Statistical analysis showed A336C/A336T/
T337C variations were closely associated with G1896A
variation and more prone to occur in samples with
A1896 variants, therefore, A336C/A336T/T337C were
naturally occurring polymorphisms as well as G1896A. In
addition, chronic hepatitis B patients with C336/T336/
C337 variants had a significant lower rate of severely ele-
vated serum HBV DNA levels than those with the wild
type A336/T337, which was in agreement with previous
report that A336C/A336T/T337C variations caused the
decreases in serum HBV DNA levels and HBV replica-
tion [13].
The natural history of chronic HBV infection can be
divided into four phases: immune tolerance, HBeAg-posi-
tive chronic hepatitis, inactive HBsAg carrier and HBeAg-
negative chronic hepatitis [23]. The common features of
immune tolerance phase and HBeAg-positive chronic
hepatitis phase are positive for HBeAg and high levels of
serum HBV DNA, whereas inactive HBsAg carrier phase
is characterized by the absence of HBeAg and decrease in
H B VD N A .T h e r e f o r e ,s p o n t a n e o u sH B e A gl o s sd u r i n g
the course of chronic HBV infection usually correlates
with a drastic decrease in serum HBV DNA and disap-
pearance of biochemical markers of hepatitis [23-27]. In
this study, the rate of severely elevated serum HBV DNA
levels in HBeAg-positive patients was higher than that in
HBeAg-negative patients, supporting that HBeAg expres-
sion was strongly related to HBV replication and high
serum HBV DNA levels. However, binary regression ana-
lysis showed that serum HBV DNA levels <6.0 was not an
independent factor associating with spontaneous HBeAg
loss. One retrospective and follow-up study carried out in
Taiwan showed that rates of spontaneous HBeAg loss
were not statistically different between patients with low
and high baseline serum HBV DNA levels and baseline
serum HBV DNA levels were not independent factors for
predicting HBeAg loss [5]. Taken together, these findings
did not support that serum HBV DNA levels were inde-
pendent factors associating with spontaneous HBeAg loss
in chronic hepatitis B.
HBeAg loss can occur spontaneously or secondary to
treatment with nucleoside/nucleotide analogs and inter-
feron. Spontaneous HBeAg loss, which occurs annually
in as many as 10% to 20% of those with HBeAg-positive
hepatitis, is an important landmark in the natural history
of chronic HBV infection. In a population-based study of
1536 Alaskan natives who had HBV infection in adult-
hood, spontaneous loss was found in 70% during the
10-year follow-up period [28]. Factors associated with a
higher rate of spontaneous HBeAg loss include the pre-
sence of A1896 variant and genotype B [5,23,29]. One
cross-sectional study from China found that among 223
HBV DNA-positive chronic patients, the G1896A varia-
tion was found in 47/128 HBeAg-negative patients and
5/95 HBeAg-positive patients [3]. Similarly, in another
multicenter study of 449 chronic hepatitis B patients with
detectable HBV DNA, the A1896 variant was present in
7% of HBeAg-positive and 36% of HBeAg-negative
patients [11]. This study showed A1896 variant was pre-
sent in 14/77 (18.2%) HBeAg-positive patients and 61/89
(68.5%) HBeAg-negative patients. Furthermore, binary
regression analysis showed patients who presented with
A1896 variant, as compared to having wild type G1896,
were nearly 7.8 times more likely to occur spontaneous
Table 4 Binary logistic regression analysis of potential
factors associating with spontaneous HBeAg loss
Factors Odds
Ration
95%CI Wald
value
P
value
A336C/A336T/T337C
variations
A336/T337 1
C336/T336/C337 3.2 1.2-8.5 5.2 0.02
G1896 variation
G1896 1
A1896 7.8 3.3-
18.5
21.4 <0.001
HBV genotype
B 4.1 1.8-9.2 11.8 0.001
C1
serum HBV DNA levels
<6 1
≧6 0.5 0.2-1.1 3.3 0.07
Age
<35 1
≧35 1.9 0.8-4.1 2.4 0.12
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which supporting the presence of A1896 variants was
one of the major mechanisms to explain spontaneous
HBeAg loss in the natural history of chronic HBV
infection.
In this study, genotypes B and C accounted for 52.4%
(87/166) and 47.6% (79/166) of chronic hepatitis B
patients respectively. HBV genotype B was thought to
be related to spontaneous HBeAg loss. One retrospec-
tive study of 146 Taiwanese adult HBeAg-positive hepa-
titis B carriers showed genotype C patients had a
significantly lower rate of spontaneous HBeAg loss than
genotype B patients [5]. Another retrospective study of
332 Chinese patients with a mean follow-up of 48
months, genotype B patients had a significantly lower
prevalence of HBeAg at presentation and a significantly
higher rate of spontaneous HBeAg loss during follow-up
[3]. In agreement with the above two reports, chronic
patients with genotype B were demonstrated to have a
higher likelihood of spontaneous HBeAg loss than those
with genotype C (OR = 4.1, 95% CI = 1.8-9.2, P =
0.001) in this study. It was more interesting to find that
chronic hepatitis B patients with C336/T336/C337 var-
iants had a significantly lower HBeAg-positive percen-
tage than those with the wild type A336/T337, and
moreover, logistic regression analysis showed the likeli-
hood of HBeAg loss among chronic hepatitis B patients
with C336/T336/C337 variants was nearly 3.2 times that
of those with the wild type A336/T337 (OR = 3.2, 95%
CI = 1.2-8.5, P = 0.02), which demonstrated that the
presence of C336/T336/C337 variants was an indepen-
dent factor associating with spontaneous HBeAg loss.
Therefore, A336C/A336T/T337C variations were pro-
posed to be another major mechanism to explain spon-
taneous HBeAg loss in the natural history of chronic
HBV infection as well as G1896A variation and geno-
type B [7,8,30,31]. Age was thought of as another factor
influencing spontaneous HBeAg loss, but the real signif-
icance of age is now existence controversy. One long-
term follow-up study in Alaska showed that older HBV
carriers were more likely than younger carriers to clear
HBeAg [28]. The other follow-up study in Taiwan
showed age ≤35 years was an independent factor asso-
ciating with spontaneous HBeAg loss [5]. In this study
chronic hepatitis B patients were grouped into age <35
years and age ≧35 years, and HBeAg-positive percentage
were higher in group age <35 years than that in group
age ≧35 years, but binary regression analysis in this
study showed that age ≧35 years were not an indepen-
dent factor associating with spontaneous HBeAg loss
(OR = 1.8, 95% CI = 0.8-4.1, P = 0.12), which was not
agreement with one of the above two studies. The possi-
ble reason was below: (i) cross-sectional study was used
in this study, whereas retrospective and follow-up
studies were adopted in the above two studies; (ii) age
was a dynamic increasing variable.
In conclusion, A336C/A336T/T337C were naturally
occurring polymorphisms in HBV core gene, and the
presence of C336/T336/C337 variants was first demon-
strated to be an independent factor associating with
spontaneous HBeAg loss. This study also demonstrated
that the presence of A1896 variant and HBV genotype B
were also independent factors related to spontaneous
HBeAg loss in chronic hepatitis B patients.
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